{"id":"W2101058297","doi":"10.3747/co.21.1899","title":"Cost-Effectiveness of Pazopanib in Advanced Soft-Tissue Sarcoma in Canada","year":2014,"lang":"en","type":"article","venue":"Current Oncology","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; GlaxoSmithKline (Canada)","funders":"GlaxoSmithKline","keywords":"Pazopanib; Medicine; Placebo; Oncology; Clinical trial; Soft tissue sarcoma; Internal medicine; Adverse effect; Cost effectiveness; Health care; Sarcoma; Cancer; Sunitinib; Alternative medicine; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":true,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001100978,0.0005388388,0.0005142179,0.001298828,0.001143365,0.001912653,0.001105026,0.0006073916,0.003486966],"category_scores_gemma":[0.006356106,0.000288327,0.001142104,0.002063271,0.000592743,0.0005420491,0.0006594248,0.0009076625,0.0001235459],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.08884574,"about_ca_system_score_gemma":0.07971645,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9861978,"about_ca_topic_score_gemma":0.9832261,"domain_scores_codex":[0.999023,0.0002793075,0.00003695179,0.00008253016,0.0003434677,0.0002348563],"domain_scores_gemma":[0.9983877,0.0004430694,0.0001723689,0.00002818435,0.0006420203,0.0003268075],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","study_design_scores_codex":[0.003814396,0.0004285145,0.1963315,0.001644904,0.002408784,0.001291826,0.000336524,0.6125314,0.0009442889,0.02438213,0.03163712,0.1242486],"study_design_scores_gemma":[0.003319288,0.0007482992,0.2062883,0.001197109,0.001982461,0.0007707476,0.00111266,0.7381626,0.001137671,0.01363343,0.03141725,0.000230304],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8739985,0.02750288,0.005500481,0.0177774,0.0002109803,0.0008324292,0.02451216,0.0001873118,0.04947785],"genre_scores_gemma":[0.9915637,0.003416462,0.001078349,0.0003122252,0.00001397381,0.00006265436,0.002014552,0.00001131813,0.001526875],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08884574,"threshold_uncertainty_score":0.644624,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08267323360232505,"score_gpt":0.4026817324119329,"score_spread":0.3200084988096079,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}